EpiCept's Merger

EpiCept raised a round of funding on August 26, 2013. Investors include Immune Pharmaceuticals.

EpiCept is focused on unmet needs in the treatment of pain and cancer. The Company's portfolio of pharmaceutical product candidates includes several pain therapies in clinical development and a lead o…

Articles about EpiCept's Merger: